Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

When Columbus resident Jennifer Roberts’ family gets together for the holidays, they typically play a few games of bingo for ...

Charlotte Proud, 33, was diagnosed with Brittle Bone Disease - osteogenesis imperfecta - at just two years old, and has ...

Charlotte Proud, a Sunderland University apprentice born with Osteogenesis Imperfecta (Brittle Bone Disease), is determined ...

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

" Jay & Pamela " will be officially premiered on Tuesday, March 4, 2025, at 10/9C. Viewers can tune into the network to see the series and experience the inspirational journey of the couple. For those ...

As Ghana’s energy sector grows, Engen Ghana continues to stand out for its commitment to quality, innovation, and community development. With nearly three decades of operations, Engen Ghana has built ...

An England-wide study of 331 rare diseases in over 58 million people co-led by UCL researchers has identified eight rare ...

Bills proposing to restrict abortion are rooted in ideology rather than medical evidence, retired obstetrician Jone Sampson argues.

an Aging Dome Tries to Stay SuperHow London’s Taxi Dr Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025 Alvelestat ...

NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...